Literature DB >> 17200870

Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22.

Tomoki Kikuchi1, Taeko K Naruse, Makoto Onizuka, Suyun Li, Tetsuaki Kimura, Akira Oka, Yasuo Morishima, Jerzy K Kulski, Shingo Ichimiya, Noriyuki Sato, Hidetoshi Inoko.   

Abstract

Despite matching donors and recipients for the human leukocyte antigens (HLAs) expressed by the major histocompatibility genomic region of the short arm of chromosome 6, several recipients still develop acute graft-versus-host disease (aGVHD) after bone marrow transplantation (BMT). This is possibly due to non-HLA gene polymorphisms, such as minor histocompatibility antigens (mHas) and genes coding for cytokines. However, a detailed genetic background for aGVHD has not yet been established. To find novel susceptibility and/or protective loci for aGVHD, a whole genome-wide association study of donors and recipients needs to be performed. As the first step to such a study, we retrospectively analyzed polymorphisms of 155 microsatellite markers spread across the long arm of chromosome 22 in 70 pairs of HLA-matched unrelated BMT donors and recipients. We performed individual typing and then compared the markers' allele frequencies (1) between all the aGVHD (grades III and IV GVHD) and GVHD-free (grade 0 GVHD) groups in donors and recipients and (2) between the aGVHD and aGVHD-free groups in donor/recipient pairs that were matched and mismatched for the microsatellite marker's allele. Screening of the microsatellite markers revealed five loci with a significant difference between the aGVHD and GVHD-free groups and revealed eight loci on chromosome 22, where the microsatellite allele mismatched markers were associated with aGVHD. This screening analysis suggests that several aGVHD-associated susceptible and protective loci exist on chromosome 22, which may encompass novel gene regions that need to be elucidated for their role in aGVHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200870     DOI: 10.1007/s00251-006-0186-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  49 in total

1.  A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder.

Authors:  Lynn E DeLisi; Sarah H Shaw; Timothy J Crow; Gail Shields; Angela B Smith; Veronica W Larach; Nigel Wellman; Josephine Loftus; Betsy Nanthakumar; Kamran Razi; John Stewart; Margherita Comazzi; Antonio Vita; Thomas Heffner; Robin Sherrington
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

2.  Identification and cloning of putative human neuronal voltage-gated calcium channel gamma-2 and gamma-3 subunits: neurologic implications.

Authors:  J L Black; V A Lennon
Journal:  Mayo Clin Proc       Date:  1999-04       Impact factor: 7.616

Review 3.  Minors come of age: Minor histocompatibility antigens and graft-versus-host disease.

Authors:  Nelson J Chao
Journal:  Biol Blood Marrow Transplant       Date:  2004-04       Impact factor: 5.742

4.  IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.

Authors:  Lidia Karabon; Barbara Wysoczanska; Katarzyna Bogunia-Kubik; Krzysztof Suchnicki; Andrzej Lange
Journal:  Hum Immunol       Date:  2005-03-19       Impact factor: 2.850

5.  Prospective evaluation of neurological complications after allogeneic bone marrow transplantation.

Authors:  P Sostak; C S Padovan; T A Yousry; G Ledderose; H-J Kolb; A Straube
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

6.  Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation.

Authors:  Charles Mullighan; Sue Heatley; Kathleen Doherty; Ferenc Szabo; Andrew Grigg; Timothy Hughes; Anthony Schwarer; Jeff Szer; Brian Tait; Bik To; Peter Bardy
Journal:  Transplantation       Date:  2004-02-27       Impact factor: 4.939

7.  Tom1 (target of Myb 1) is a novel negative regulator of interleukin-1- and tumor necrosis factor-induced signaling pathways.

Authors:  Megumi Yamakami; Hideyoshi Yokosawa
Journal:  Biol Pharm Bull       Date:  2004-04       Impact factor: 2.233

8.  Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.

Authors:  T Sasazuki; T Juji; Y Morishima; N Kinukawa; H Kashiwabara; H Inoko; T Yoshida; A Kimura; T Akaza; N Kamikawaji; Y Kodera; F Takaku
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

9.  Heme oxygenase: a novel target for the modulation of the inflammatory response.

Authors:  D Willis; A R Moore; R Frederick; D A Willoughby
Journal:  Nat Med       Date:  1996-01       Impact factor: 53.440

10.  Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.

Authors:  John M Routes; Sharon Ryan; Kristin Morris; Rayna Takaki; Adelheid Cerwenka; Lewis L Lanier
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

View more
  3 in total

1.  Genetic similarity of chromosome 6 between patients receiving hematopoietic stem cell transplantation and HLA matched sibling donors.

Authors:  Hannu Turpeinen; Liisa Volin; Lauri Nikkinen; Pauli Ojala; Aarno Palotie; Janna Saarela; Jukka Partanen
Journal:  Haematologica       Date:  2009-03-10       Impact factor: 9.941

2.  Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation.

Authors:  Christian Harkensee; Akira Oka; Makoto Onizuka; Peter G Middleton; Hidetoshi Inoko; Hirofumi Nakaoka; Andrew R Gennery; Kiyoshi Ando; Yasuo Morishima
Journal:  Immunogenetics       Date:  2013-03-09       Impact factor: 2.846

3.  Mapping MHC-resident transplantation determinants.

Authors:  Mari Malkki; Ted A Gooley; Mary M Horowitz; Lena Absi; Frank T Christiansen; Jan J Cornelissen; Anne Dormoy; Valerie Dubois; Katia Gagne; Eliane Gluckman; Michael D Haagenson; Machteld Oudshoorn; Stephen Spellman; Effie W Petersdorf
Journal:  Biol Blood Marrow Transplant       Date:  2007-08       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.